Gabapentin Patent Expiration
Gabapentin was first introduced by Viatris Specialty Llc
Gabapentin Patents
Given below is the list of patents protecting Gabapentin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Gralise | US7438927 | Methods of treatment using a gastric retained gabapentin dosage |
Feb 26, 2024
(Expired) | Almatica |
| Neurontin |
US7256216 (Pediatric) | Liquid pharmaceutical compositions |
Nov 28, 2022
(Expired) | Viatris |
| Gralise | US7731989 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Gralise | US8192756 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Gralise | US8252332 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Gralise | US8333992 | Gastric retained gabapentin dosage form |
Oct 25, 2022
(Expired) | Almatica |
| Neurontin | US7256216 | Liquid pharmaceutical compositions |
May 28, 2022
(Expired) | Viatris |
| Gralise | US6723340 | Optimal polymer mixtures for gastric retentive tablets |
Oct 25, 2021
(Expired) | Almatica |
| Gralise | US6488962 | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
Jun 20, 2020
(Expired) | Almatica |
| Neurontin |
US6054482 (Pediatric) | Lactam-free amino acids |
Oct 25, 2017
(Expired) | Viatris |
| Neurontin | US6054482 | Lactam-free amino acids |
Apr 25, 2017
(Expired) | Viatris |
| Gralise | US6340475 | Extending the duration of drug release within the stomach during the fed mode |
Sep 19, 2016
(Expired) | Almatica |
| Gralise | US6635280 | Extending the duration of drug release within the stomach during the fed mode |
Sep 19, 2016
(Expired) | Almatica |
Gabapentin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List